| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Dihydrocodeine tartrate 10 mg and paracetamol 500 mg oral tablet | Has active ingredient | False | Dihydrocodeine tartrate | Inferred relationship | Some |  | 
| Dihydrocodeine tartrate 20 mg and paracetamol 500 mg oral tablet | Has active ingredient | False | Dihydrocodeine tartrate | Inferred relationship | Some |  | 
| Dihydrocodeine tartrate 30 mg and paracetamol 500 mg oral tablet | Has active ingredient | False | Dihydrocodeine tartrate | Inferred relationship | Some |  | 
| paracetamol + dihydrokodein | Has active ingredient | False | Dihydrocodeine tartrate | Inferred relationship | Some |  | 
| acetylsalicylsyra + koffein + dihydrokodeinbitartrat | Has active ingredient | False | Dihydrocodeine tartrate | Inferred relationship | Some |  | 
| Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule | Has active ingredient | False | Dihydrocodeine tartrate | Inferred relationship | Some |  | 
| paracetamol + koffein + dihydrokodeinbitartrat | Has active ingredient | False | Dihydrocodeine tartrate | Inferred relationship | Some |  | 
| Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | False | Dihydrocodeine tartrate | Inferred relationship | Some |  | 
| Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | False | Dihydrocodeine tartrate | Inferred relationship | Some |  | 
| dihydrokodeintartrat 60 mg, tablett med modifierad frisättning | Has active ingredient | False | Dihydrocodeine tartrate | Inferred relationship | Some |  | 
| dihydrokodeintartrat 120 mg, tablett med modifierad frisättning | Has active ingredient | False | Dihydrocodeine tartrate | Inferred relationship | Some |  | 
| dihydrokodeintartrat 90 mg, tablett med modifierad frisättning | Has active ingredient | False | Dihydrocodeine tartrate | Inferred relationship | Some |  | 
| dihydrokodeintartrat 50 mg/ml, injektionsvätska, lösning, ampull 1 ml | Has active ingredient | False | Dihydrocodeine tartrate | Inferred relationship | Some |  | 
| Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | False | Dihydrocodeine tartrate | Inferred relationship | Some | 1 | 
| Dihydrocodeine tartrate 10 mg and paracetamol 500 mg oral tablet | Has basis of strength substance (attribute) | False | Dihydrocodeine tartrate | Inferred relationship | Some | 2 | 
| Dihydrocodeine tartrate 20 mg and paracetamol 500 mg oral tablet | Has basis of strength substance (attribute) | False | Dihydrocodeine tartrate | Inferred relationship | Some | 2 | 
| Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule | Has basis of strength substance (attribute) | False | Dihydrocodeine tartrate | Inferred relationship | Some | 1 | 
| Dihydrocodeine tartrate 10 mg and paracetamol 500 mg oral tablet | Has active ingredient | False | Dihydrocodeine tartrate | Inferred relationship | Some | 1 | 
| Dihydrocodeine tartrate 10 mg and paracetamol 500 mg oral tablet | Has basis of strength substance (attribute) | True | Dihydrocodeine tartrate | Inferred relationship | Some | 1 | 
| Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | False | Dihydrocodeine tartrate | Inferred relationship | Some | 1 | 
| Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | False | Dihydrocodeine tartrate | Inferred relationship | Some | 1 | 
| Dihydrocodeine tartrate 30 mg and paracetamol 500 mg oral tablet | Has active ingredient | False | Dihydrocodeine tartrate | Inferred relationship | Some | 1 | 
| Dihydrocodeine tartrate 30 mg and paracetamol 500 mg oral tablet | Has basis of strength substance (attribute) | True | Dihydrocodeine tartrate | Inferred relationship | Some | 1 | 
| Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | False | Dihydrocodeine tartrate | Inferred relationship | Some | 3 | 
| Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | False | Dihydrocodeine tartrate | Inferred relationship | Some | 3 | 
| Dihydrocodeine tartrate 20 mg and paracetamol 500 mg oral tablet | Has active ingredient | False | Dihydrocodeine tartrate | Inferred relationship | Some | 1 | 
| Dihydrocodeine tartrate 20 mg and paracetamol 500 mg oral tablet | Has basis of strength substance (attribute) | True | Dihydrocodeine tartrate | Inferred relationship | Some | 1 | 
| Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | False | Dihydrocodeine tartrate | Inferred relationship | Some | 3 | 
| Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule | Has active ingredient | False | Dihydrocodeine tartrate | Inferred relationship | Some | 3 | 
| Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule | Has basis of strength substance (attribute) | False | Dihydrocodeine tartrate | Inferred relationship | Some | 3 | 
| Product containing precisely dihydrocodeine tartrate 90 milligram/1 each prolonged-release oral tablet (clinical drug) | Has basis of strength substance (attribute) | True | Dihydrocodeine tartrate | Inferred relationship | Some | 1 | 
| Product containing precisely dihydrocodeine tartrate 90 milligram/1 each prolonged-release oral tablet (clinical drug) | Has precise active ingredient | True | Dihydrocodeine tartrate | Inferred relationship | Some | 1 | 
| Product containing precisely dihydrocodeine tartrate 60 milligram/1 each prolonged-release oral tablet (clinical drug) | Has basis of strength substance (attribute) | True | Dihydrocodeine tartrate | Inferred relationship | Some | 1 | 
| Product containing precisely dihydrocodeine tartrate 60 milligram/1 each prolonged-release oral tablet (clinical drug) | Has precise active ingredient | True | Dihydrocodeine tartrate | Inferred relationship | Some | 1 | 
| Product containing precisely dihydrocodeine tartrate 120 milligram/1 each prolonged-release oral tablet (clinical drug) | Has precise active ingredient | True | Dihydrocodeine tartrate | Inferred relationship | Some | 1 | 
| Product containing precisely dihydrocodeine tartrate 120 milligram/1 each prolonged-release oral tablet (clinical drug) | Has basis of strength substance (attribute) | True | Dihydrocodeine tartrate | Inferred relationship | Some | 1 | 
| Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | False | Dihydrocodeine tartrate | Inferred relationship | Some | 1 | 
| Dihydrocodeine tartrate 20 mg and paracetamol 500 mg oral tablet | Has precise active ingredient | False | Dihydrocodeine tartrate | Inferred relationship | Some | 2 | 
| Dihydrocodeine tartrate 30 mg and paracetamol 500 mg oral tablet | Has precise active ingredient | True | Dihydrocodeine tartrate | Inferred relationship | Some | 1 | 
| Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule | Has precise active ingredient | False | Dihydrocodeine tartrate | Inferred relationship | Some | 1 | 
| Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | False | Dihydrocodeine tartrate | Inferred relationship | Some | 3 | 
| Dihydrocodeine tartrate 10 mg and paracetamol 500 mg oral tablet | Has precise active ingredient | False | Dihydrocodeine tartrate | Inferred relationship | Some | 2 | 
| Dihydrocodeine tartrate 2 mg/mL oral solution | Has precise active ingredient | True | Dihydrocodeine tartrate | Inferred relationship | Some | 1 | 
| Dihydrocodeine tartrate 2 mg/mL oral solution | Has basis of strength substance (attribute) | True | Dihydrocodeine tartrate | Inferred relationship | Some | 1 | 
| dihydrokodeintartrat 50 mg/ml, injektionsvätska, lösning, ampull | Has precise active ingredient | False | Dihydrocodeine tartrate | Inferred relationship | Some | 1 | 
| dihydrokodeintartrat 50 mg/ml, injektionsvätska, lösning, ampull | Has basis of strength substance (attribute) | False | Dihydrocodeine tartrate | Inferred relationship | Some | 1 | 
| Product containing precisely dihydrocodeine tartrate 50 milligram/1 milliliter conventional release solution for injection (clinical drug) | Has precise active ingredient | True | Dihydrocodeine tartrate | Inferred relationship | Some | 1 | 
| Product containing precisely dihydrocodeine tartrate 50 milligram/1 milliliter conventional release solution for injection (clinical drug) | Has basis of strength substance (attribute) | True | Dihydrocodeine tartrate | Inferred relationship | Some | 1 | 
| Product containing precisely dihydrocodeine tartrate 40 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | True | Dihydrocodeine tartrate | Inferred relationship | Some | 1 | 
| Product containing precisely dihydrocodeine tartrate 40 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | True | Dihydrocodeine tartrate | Inferred relationship | Some | 1 | 
| Dihydrocodeine tartrate 30 mg oral tablet | Has basis of strength substance (attribute) | True | Dihydrocodeine tartrate | Inferred relationship | Some | 1 | 
| Dihydrocodeine tartrate 30 mg oral tablet | Has precise active ingredient | True | Dihydrocodeine tartrate | Inferred relationship | Some | 1 | 
| Product containing precisely dihydrocodeine tartrate 10 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | True | Dihydrocodeine tartrate | Inferred relationship | Some | 1 | 
| Product containing precisely dihydrocodeine tartrate 10 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | True | Dihydrocodeine tartrate | Inferred relationship | Some | 1 | 
| Dihydrocodeine tartrate 2.42 mg/mL oral solution | Has precise active ingredient | True | Dihydrocodeine tartrate | Inferred relationship | Some | 1 | 
| Dihydrocodeine tartrate 2.42 mg/mL oral solution | Has basis of strength substance (attribute) | True | Dihydrocodeine tartrate | Inferred relationship | Some | 1 | 
| Dihydrocodeine tartrate 10 mg and paracetamol 500 mg oral tablet | Has precise active ingredient | True | Dihydrocodeine tartrate | Inferred relationship | Some | 1 | 
| Dihydrocodeine tartrate 20 mg and paracetamol 500 mg oral tablet | Has precise active ingredient | True | Dihydrocodeine tartrate | Inferred relationship | Some | 1 | 
| Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule | Has basis of strength substance (attribute) | True | Dihydrocodeine tartrate | Inferred relationship | Some | 2 | 
| Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule | Has precise active ingredient | True | Dihydrocodeine tartrate | Inferred relationship | Some | 2 | 
| Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | True | Dihydrocodeine tartrate | Inferred relationship | Some | 2 | 
| Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | True | Dihydrocodeine tartrate | Inferred relationship | Some | 2 | 
| Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | True | Dihydrocodeine tartrate | Inferred relationship | Some | 2 | 
| Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | True | Dihydrocodeine tartrate | Inferred relationship | Some | 2 |